Report: Google to Settle With DOJ Over Illegal Pharma Ads

  |  May 13, 2011   |  Comments

Company has set aside $500 million for a possible DOJ settlement.

Google has set aside $500 million in anticipation of a settlement with the Department of Justice, the company revealed in its quarterly report to the Securities and Exchange Commission, filed Tuesday. According to a report by the Wall Street Journal, that settlement relates to Google's knowing acceptance of ads from online pharmacies that violate U.S. laws.

"In May 2011, in connection with a potential resolution of an investigation by the United States Department of Justice into the use of Google advertising by certain advertisers, we accrued $500 million for the three month period ended March 31, 2011," the SEC filing stated, adding, "Although we cannot predict the ultimate outcome of this matter, we believe it will not have a material adverse effect on our business."

Google declined to comment on the matter today, as did the Food and Drug Administration, which is reportedly working alongside the DOJ to investigate the company's practices. The DOJ had not returned requests for further information at the time of publish.

In 2003 Google said it would stop accepting ads from unlicensed pharmacies, and in 2007 the company, along with Microsoft and Yahoo, agreed to pay a combined $31.5 million fine in relation to the sale of ads for illegal gambling sites.

In September, Google attempted to deter the placement of illegal ads on its platform by filing a civil lawsuit in federal court against advertisers it believed deliberately broke its rules. In a blog post published at the time Michael Zwibelman, the company's Litigation Counsel, wrote, "As we and others build new safeguards and guidelines, rogue online pharmacies always try new tactics to get around those protections and illegally sell drugs on the web… This has meant that despite our best efforts - from extensive verification procedures, to automated keyword blocking, to changing our ads policies - a small percentage of pharma ads from these rogue companies is still appearing on Google."

According to the WSJ report, however, the DOJ is currently trying to establish whether or not Google executives were in fact aware of the illegal ads it was selling, and turned a blind eye to that activity.



Jack Marshall

Jack Marshall was a staff writer and stats editor for ClickZ News from 2007 until August 2011. 

COMMENTSCommenting policy

comments powered by Disqus

Get the ClickZ Search newsletter delivered to you. Subscribe today!



Featured White Papers

2015 Holiday Email Guide

2015 Holiday Email Guide
The holidays are just around the corner. Download this whitepaper to find out how to create successful holiday email campaigns that drive engagement and revenue.

Three Ways to Make Your Big Data More Valuable

Three Ways to Make Your Big Data More Valuable
Big data holds a lot of promise for marketers, but are marketers ready to make the most of it to drive better business decisions and improve ROI? This study looks at the hidden challenges modern marketers face when trying to put big data to use.